S-nitrosylation抑制Notch-1活化诱导间充质干细胞向肝细胞定向分化的机制研究
批准号:
32060232
项目类别:
地区科学基金项目
资助金额:
35.0 万元
负责人:
叶俊松
依托单位:
学科分类:
共性生物技术
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
叶俊松
中文摘要
间充质干细胞(MSC)分化成肝细胞的细胞移植或生物人工肝制备在肝脏疾病中有广阔的应用前景,但MSC分化成肝细胞的机制亟需阐明。研究发现MSC高表达Notch-1,抑制Notch-1及Notch信号通路活化促进MSC分化成肝细胞;预实验发现,Notch-1发生巯基亚硝基化(S-nitrosylation, SNO)抑制Notch-1自身活化,且SNO内源性抑制剂促进Notch-1表达,而SNO激动剂可促进MSC向肝细胞分化。据此提出假设:Notch-1发生亚硝基化抑制Notch-1及其信号通路的活化,促进MSC向肝细胞分化。课题拟开展如下研究:验证Notch-1参与脐带间充质干细胞向肝细胞的定向分化;证明SNO可抑制Notch-1活化;阐明Notch-1经其半胱氨酸位点诱发的SNO调控脐带间充质干细胞向肝细胞定向分化的机制。结果有望阐明MSC向肝细胞分化的分子机制及为肝病治疗提供实验基础。
英文摘要
Cell transplantation or the preparation of biological artificial liver derived from mesenchymal stem cells (MSC) differentiating into hepatocytes have a broad application prospect in end-stage liver diseases, but the mechanism of induced differentiation of MSC into hepatocytes needs to be clarified. Studies have found that Notch-1 is highly expressed in MSC, and inhibition of Notch-1 and its downstream signaling pathway can promote the differentiation of MSC into hepatocytes. The pilot experiments showed that S-nitrosylation (SNO) of Notch-1 inhibited the activation of Notch-1, and endogenous SNO inhibitors promoted the expression of Notch-1, while exogenous SNO agonists promoted the differentiation of MSC into liver cells. Based on this, the hypothesis was put forward: the regulation of S-nitrosylation of Notch-1(SNO.Notch-1) will inhibit the activation of Notch-1 and Notch signaling pathway, which induces the differentiation of MSCs into hepatocytes. This project intends to study: verify that Notch-1 is involved in the differentiation of umbilical cord mesenchymal stem cells into hepatocytes; prove that S-nitrosylation can inhibit the activation of Notch-1; elucidate that Notch-1 regulates the differentiation of umbilical cord mesenchymal stem cells into hepatocytes by S-nitrosylation induced by Notch-1 cysteine site. In this way, the mechanism of MSCs differentiation into hepatocytes would be elucidated and would provide the experimental basis for the treatment of liver diseases.
项目聚焦于间充质干细胞(MSCs)分化为肝样细胞的机制研究以及其在肝纤维化治疗中的应用。肝纤维化是慢性肝病的重要病理过程,目前临床治疗手段有限,我们通过Meta分析及系统综述等方法对已有的研究进行分析发现,MSCs的多向分化潜能和免疫调节能力为肝纤维化治疗提供了新的思路。此外我们进一步调研发现MSCs通过体外诱导成肝样细胞(HLCs)在肝纤维化及由肝纤维化迁延发展形成的终末期肝病中均有非常大的治疗潜力,且Notch信号通路在干细胞定向诱导分化成肝样细胞这一过程中的调控作用至关重要。.在本研究中,我们首先深入探究了MSCs分化为肝样细胞的关键机制。通过体外诱导实验发现,Notch信号通路的抑制促进了MSCs向肝样细胞的分化,我们通过转录组测序分析发现Notch信号通路在分化过程中主要作用为信号的转导,其受体及配体在分化后表达下降。随后我们发现在细胞分化过程中细胞内源性NO的表达逐渐升高。为深入理解分化机制,进一步的机制研究揭示了表观遗传修饰中一种由NO介导的亚硝基化修饰在调控MSCs分化中的关键作用,其主要针对于Notch信号通路细胞外结构域进行靶向修饰,为精准调控分化过程提供了潜在靶点。.在MSCs治疗肝纤维化的研究中,我们构建了多种肝纤维化动物模型,评估了MSCs的治疗效果。实验结果显示,MSCs能够显著改善肝纤维化程度,降低肝组织中胶原蛋白的沉积,其机制与MSCs的抗炎、免疫调节以及分化为肝样细胞替代受损肝细胞有关。我们的研究为提高MSCs治疗效率提供了理论依据。.本项目共发表SCI论文7篇,中文核心2篇,省级刊物1篇,毕业硕士研究生1名,培养在读硕士研究生6名,项目研究成果为MSCs在肝病治疗中的应用提供了重要的理论支持和实验依据,具有一定的临床转化前景。
国内基金
海外基金